HomeGLMD • NASDAQ
add
Galmed Pharmaceuticals Ltd
Previous close
$0.92
Day range
$0.88 - $0.95
Year range
$0.74 - $3.61
Market cap
6.74M USD
Avg Volume
4.19M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 2.10M | 4.18% |
Net income | -1.89M | 1.15% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -2.07M | -3.15% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 19.05M | 11.15% |
Total assets | 21.58M | 3.03% |
Total liabilities | 2.47M | -1.67% |
Total equity | 19.11M | — |
Shares outstanding | 5.46M | — |
Price to book | 0.26 | — |
Return on assets | -23.52% | — |
Return on capital | -26.43% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -1.89M | 1.15% |
Cash from operations | -1.94M | -81.86% |
Cash from investing | -3.00K | -100.49% |
Cash from financing | 289.00K | -96.53% |
Net change in cash | -1.65M | -120.91% |
Free cash flow | -1.38M | -133.56% |
About
Founded
2000
Website
Employees
5
